A Phase I, Randomized, Single-Dose Study to Evaluate the Biosimilarity of HOT-3010 to Adalimumab Among Healthy Chinese Male Subjects

Objective: This study explored the bioequivalence of a proposed biosimilar HOT-3010 vs. its reference product (adalimumab) among healthy Chinese male subjects. The study also investigated the tolerance, immunogenicity, and pharmacokinetics (PK). Methods: A randomized, double-blind, two-arm, parallel...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Front Pharmacol
Главные авторы: Zhang, Hong, Chen, Hong, Li, Xiaojiao, Wu, Min, Zhu, Xiaoxue, Li, Cuiyun, Liu, Jingrui, Wei, Haijing, Hu, Yue, Wang, Jingjing, Yang, Yongmin, Zhu, Xiangyang, Ding, Yanhua
Формат: Artigo
Язык:Inglês
Опубликовано: Frontiers Media S.A. 2021
Предметы:
Pharmacology
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC8190825/
https://ncbi.nlm.nih.gov/pubmed/34122068
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2021.646171
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы